Hydrocephalus Articles & Analysis
15 news found
The second-generation ReFlow Mini Flusher breakthrough device is indicated for use in patients living with hydrocephalus or similar conditions like IIH that may be treated with a shunt. ...
Zachary was born with spina bifida and hydrocephalus, both of which were diagnosed while in utero. As with many children in the hydrocephalus community, most parents have never heard of the condition, nor understand how it could impact their child’s life, as well as impact their own emotional health with concern, worry, and ...
Many patients require multiple brain surgeries to manage their hydrocephalus and their shunt. One patient even required 11 different procedures. ...
The second-generation, FDA-cleared ReFlow Mini Flusher is indicated for use in patients living with hydrocephalus or similar conditions. The reduced size and profile of the technology is designed to better support a broader hydrocephalus patient population, from infants to older adults. ...
At just 1 pound and 12 ounces, her son, Sutton, arrived with life-threatening health issues, including hydrocephalus - a neurological disorder caused by an abnormal buildup of cerebrospinal fluid in the brain that affects more than one million ...
Food and Drug Administration (FDA) cleared the ReFlow® System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid (CSF) disorders that require shunting. ...
The SCS is being designed to be a transformative device which prevents obstruction in the cerebrospinal fluid (CSF) catheters implanted in the ventricle of the brain of patients who suffer from hydrocephalus or Normal Pressure Hydrocephalus (NPH). In January 2021, following a successful pre-submission meeting with the U.S. ...
With the new headquarters also comes a new management team of industry experts who coalesced to engineer elegant, intuitive solutions that address large unmet clinical needs in the global hydrocephalus and other CSF disorders market. Anuncia is the developer of the US FDA cleared and EU CE Marked commercial ReFlow™ Ventricular System designed to noninvasively unblock ...
Anuncia Anuncia is a spin-off of Alcyone that wants to develop devices for better treatment of hydrocephalus (the buildup of fluid in the cavities deep within the brain). ...
Anuncia is grateful that its potentially life-saving, noninvasive therapeutic medical technology is once again bringing needed awareness to the millions of patients globally, from infants to the elderly, suffering with hydrocephalus and other CSF disorders. As many as half of all surgically-implanted intracranial shunts fail in the first two years, mainly due to blockages that ...
Food and Drug Administration (FDA) Breakthrough Device Designation for its ReFlow™ System Mini intended for the treatment of CSF disorders requiring shunting such as hydrocephalus, a debilitating and life-threatening condition affecting more than 1 million U.S. patients. ...
Rhaeos is developing a wearable for the noninvasive monitoring of ventricular shunt function for hydrocephalus patients. The company is based in Evanston, Ill. During the competition, each of the five companies will have seven minutes to pitch their technology and answer questions from a panel of five judges. ...
The Alivio ReFlow ventricular system was embedded beneath the scalp of the unidentified hydrocephalus patient. Comprised of a subcutaneous “flusher” component and a ventricular catheter, the device has a “relief membrane” backup feature at the catheter’s proximal end. ...
Anuncia, Inc., a privately-held company focused on better treatment of hydrocephalus and cerebrospinal fluid dysfunctions, announced, today, the successful first-in-human implantation of its Alivio ReFlow™ Ventricular System for treatment of hydrocephalus at Boston Children’s Hospital. ...
Alcyone Lifesciences, Inc., a privately-held company focused on transforming disease modifying therapies for central nervous system (CNS) disorders today announced the separation and spin-off of its Hydrocephalus business. The new company, known as Anuncia, Inc., is an independent company focused on better treatment of Hydrocephalus and cerebrospinal fluid ...